Bloomin' Brands
BLMN:US US0942351083
Key Information
HQ:
United States
Market Cap:
$2.46bn
Primary Market:
North America
Company Information
Company Summary
Bloomin' Brands Inc is one of the world's largest casual dining companies with more than 1400 restaurants in 49 states and 21 countries. The majority of income is from restaurant operation, franchisee licenses make up the smaller proportion of income.
Antibiotics Stewardship Engagement
Analysis Overview
Scope of Policy Policy Implementation Investor Engagement
Analysis Breakdown
Scope of Policy
2/16
Does the company have a policy on antibiotics stewardship?
The company a public policy on antibiotics. In their response to FAIRR, the company stated that this is being reviewed and the company will provide a public statement once work on the policy has been completed. There is no date for the publication of this policy.
2/4
Does it cover animal-derived protein sources across all relevant species?
No policy.
0/4
Does it cover animal-derived protein sources across all operations?
No policy.
0/4
How strong is the company's commitment?
No policy.
0/4
Policy Implementation
0/18
Does the policy commit to specific targets or timelines for all species?
No information provided and/ or available.
0/5
Does the company disclose quantity of antibiotics used?
No information provided and/ or available.
0/7
Does the company commit to and/ or carries out third-party auditing and monitoring?
No information provided and/ or available.
0/6
Investor Engagement
1/4
Did the company respond to investor letter?
Bloomin' Brands responded to the investor letter with a brief statement that they are currently reviewing their antibiotics use policy. No further information was provided, and the company has not met with FAIRR. Their response is available here.
1/4
Members-only Content
To register as a member of the FAIRR network, please fill out the sign up form or if you need additional information on the FAIRR network, please contact investoroutreach@fairr.org.
Workstream Information
2019 Score:
3/38
Last Updated:
20 May 2019
2019 Resources
Phase 3 | Progress Report Antibiotics Stewardship Engagement